Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 12 2019
Historique:
received: 14 08 2019
accepted: 08 12 2019
entrez: 29 12 2019
pubmed: 29 12 2019
medline: 29 12 2019
Statut: epublish

Résumé

Metabolic diseases such as obesity, type II diabetes and hepatic steatosis are a public health concern in developed countries. The metabolic risk is gender-dependent. The constitutive androstane receptor (CAR), which is at the crossroads between energy metabolism and endocrinology, has recently emerged as a promising therapeutic agent for the treatment of obesity and type 2 diabetes. In this study we sought to determine its role in the dimorphic regulation of energy homeostasis. We tracked male and female WT and CAR deficient (CAR-/-) mice for over a year. During aging, CAR-/- male mice developed hypercortisism, obesity, glucose intolerance, insulin insensitivity, dyslipidemia and hepatic steatosis. Remarkably, the latter modifications were absent, or minor, in female CAR-/- mice. When ovariectomized, CAR-/- female mice developed identical patterns of metabolic disorders as observed in male mice. These results highlight the importance of steroid hormones in the regulation of energy metabolism by CAR. They unveil a sexually dimorphic role of CAR in the maintenance of endocrine and metabolic homeostasis underscoring the importance of considering sex in treatment of metabolic diseases.

Identifiants

pubmed: 31882815
doi: 10.1038/s41598-019-56570-0
pii: 10.1038/s41598-019-56570-0
pmc: PMC6934754
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20169

Commentaires et corrections

Type : ErratumIn

Références

Arch Toxicol. 2015 Jul;89(7):1045-55
pubmed: 25975989
Diabetes Res. 1989 Feb;10(2):85-92
pubmed: 2501061
Front Horm Res. 2016;46:54-65
pubmed: 27212264
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18831-6
pubmed: 19850873
Cell Rep. 2018 Mar 6;22(10):2690-2701
pubmed: 29514097
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
J Biol Chem. 2000 May 19;275(20):15122-7
pubmed: 10748001
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
J Biol Chem. 2006 Sep 8;281(36):26540-51
pubmed: 16825189
J Clin Endocrinol Metab. 2016 Jan;101(1):103-13
pubmed: 26574953
Sci Rep. 2016 Feb 16;6:20127
pubmed: 26879573
J Endocrinol. 2017 Jan;232(1):29-36
pubmed: 27647861
Mol Endocrinol. 2000 Nov;14(11):1897-905
pubmed: 11075820
Ann N Y Acad Sci. 2011 Jul;1229:29-37
pubmed: 21793836
Nature. 1998 Oct 8;395(6702):612-5
pubmed: 9783588
J Biol Chem. 2004 May 7;279(19):19832-8
pubmed: 15004031
Mol Endocrinol. 2004 Jul;18(7):1589-98
pubmed: 14988430
Environ Health Perspect. 2018 Jun 25;126(6):067007
pubmed: 29950287
Cell Metab. 2017 Mar 7;25(3):499-505
pubmed: 28190772
Mol Aspects Med. 2013 Feb;34(1):1-11
pubmed: 23068073
Cell Mol Neurobiol. 2019 Mar;39(2):169-180
pubmed: 30656469
Drug Metab Dispos. 2007 Sep;35(9):1700-10
pubmed: 17576804
PLoS One. 2016 Mar 09;11(3):e0148308
pubmed: 26959975
Hepatology. 2001 May;33(5):1232-8
pubmed: 11343253
Diabetes. 2015 Feb;64(2):447-58
pubmed: 25239636
Mol Cell Endocrinol. 2018 Aug 15;471:75-88
pubmed: 28774777
J Clin Invest. 1997 Mar 1;99(5):846-54
pubmed: 9062341
J Clin Invest. 2011 Jan;121(1):431-41
pubmed: 21123945
J Biol Chem. 2009 Sep 18;284(38):25984-92
pubmed: 19617349
Mol Biol Rep. 2013 Feb;40(2):1241-7
pubmed: 23079705
J Biol Chem. 2003 May 9;278(19):17277-83
pubmed: 12611900
Endocrinology. 2005 Mar;146(3):995-1002
pubmed: 15564320
J Endocrinol. 2012 Feb;212(2):111-27
pubmed: 21903862
Diabetes. 1985 Sep;34(9):911-6
pubmed: 3896900
Arch Biochem Biophys. 2003 Jan 1;409(1):207-11
pubmed: 12464260

Auteurs

Céline Lukowicz (C)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Sandrine Ellero-Simatos (S)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Marion Régnier (M)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Fabiana Oliviero (F)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Frédéric Lasserre (F)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Arnaud Polizzi (A)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Alexandra Montagner (A)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Sarra Smati (S)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Frédéric Boudou (F)

I2MC, Institut National de la Santé et de la Recherche Médicale (INSERM)-U 1048, Université de Toulouse 3 and CHU de Toulouse, Toulouse, France.

Françoise Lenfant (F)

I2MC, Institut National de la Santé et de la Recherche Médicale (INSERM)-U 1048, Université de Toulouse 3 and CHU de Toulouse, Toulouse, France.

Laurence Guzylack-Pirou (L)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Sandrine Menard (S)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Sharon Barretto (S)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Anne Fougerat (A)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Yannick Lippi (Y)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Claire Naylies (C)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Justine Bertrand-Michel (J)

Metatoul-Lipidomic Facility, MetaboHUB, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.

Afifa Ait Belgnaoui (AA)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Vassilia Theodorou (V)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Nicola Marchi (N)

Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics (UMR 5203 CNRS - U 1191 INSERM, University of Montpellier), Montpellier, France.

Pierre Gourdy (P)

I2MC, Institut National de la Santé et de la Recherche Médicale (INSERM)-U 1048, Université de Toulouse 3 and CHU de Toulouse, Toulouse, France.

Laurence Gamet-Payrastre (L)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Nicolas Loiseau (N)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Hervé Guillou (H)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France.

Laïla Mselli-Lakhal (L)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31300, Toulouse, France. laila.lakhal@inra.fr.

Classifications MeSH